EquiVita Genetics

Hasselt ·KBO/BCE: BE 0772.385.165

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	29-08-2025	29 d late	2025-00480367
31-12-2023	31-07-2024	26-08-2024	26 d late	2024-00369094
31-12-2022	31-07-2023	13-07-2023	18 d early	2023-00234558

Metric	This company	Sector median	Position in the sector
Solvency	-103.9%	55.0%	better than 10% of 174 sector peers
Net result	€-137k	€16k	better than 9% of 174 sector peers
Equity	€-40k	€70k	better than 6% of 174 sector peers
Gross operating margin	€-61k	€41k	better than 7% of 175 sector peers
Staff costs	€56k	€58k	higher than 48% of 38 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€38k
Fixed assets	21/28	€25k
Tangible fixed assets	22/27	€25k
Current assets	29/58	€13k
Amounts receivable within one year	40/41	€2k
Cash & bank	54/58	€11k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€38k
Equity	10/15	€-40k
Contributions / capital	10/11	€256k
Accumulated profits (losses)	14	€-296k
Amounts payable	17/49	€78k
Amounts payable after one year	17	€60k
Amounts payable within one year	42/48	€18k
Trade debts payable within one year	44	€7k
Income statement
Gross operating margin	9900	€-61k
Operating result	9901	€-137k
Financial income	75	€10
Financial charges	65	€284
Result before taxes	9903	€-137k
Income taxes	67/77	€300
Net result for the period	9904	€-137k
Result to be appropriated	9905	€-137k

Summary